Background Screening aims to improve health by early detection of disease or risk factors for disease. It may also influence health behaviour, either by intention or as a side effect. The aim of this review was to summarize evidence of the effects of screening, either risk factor screening or screening for early detection of disease, on health behaviour: smoking habits, diet, exercise, alcohol consumption and adherence to guidelines for healthy living.
Background
Screening aims to improve health by detecting risk factors or early detection of disease. Risk factor screening is a strategy for primary prevention. Risk factor screening, such as serum cholesterol screening for the prevention of cardiovascular disease, is often accompanied by lifestyle advice and aims to encourage screenees to improve their health behaviour. Screening for early detection of disease, or secondary prevention, aims to detect disease early, in a preclinical phase, so that more effective treatments can be offered and hence prognosis is improved. In addition, it has been proposed that such forms of screening may influence health behaviour as well. 1 -3 Not everyone is convinced that risk factor screening and screening for early detection of disease always affect health behaviour in a positive way. There is some evidence available indicating that risk factor screening and screening for early detection of disease could adversely influence health behaviour. A study performed in the 1990s concluded that screening strategies aimed at identifying persons with undiagnosed hypercholesterolemia may interfere with population strategies designed to reduce everyone's dietary intake of fat. 4 This study found that adults with normal cholesterol concentrations were discouraged from changing their diet. It has also been proposed that screening programmes could negatively affect the extent to which individuals feel they have control over their own health. Individuals might get the impression that good health can be maintained by regular visits to physicians and health checks only, thereby minimizing the role of individual behaviour. 5, 6 In general, reassurance of people with normal screening results may make them more resistant to general health recommendations and behaviour change because they may interpret the test result as confirming the good effects of their existing patterns of health behaviour: a phenomenon described as the 'certificate of health' effect. 7 It has indeed been suggested that these health behavioural effects need to be studied in the evaluation of screening as well.
5, 8 Contrary to diagnostic testing, which is performed in patients with symptoms, screening involves testing healthy persons. Before introducing a screening programme to the general public, a thorough assessment of all favourable and unfavourable effects needs to be performed. 9 A less healthy lifestyle after screening may be seen as a harmful effect of a screening programme, while an improvement in health behaviour as a benefit. Including the changes in health behaviour can thus potentially change the benefit -harm ratio of any screening strategy.
Explorations of the relations between screening and health behaviour have produced contradictory results.
1,3,5,10,11 A systematic review of studies published up to 2000 previously summarized the effects on health behaviour of screening for cholesterol level, breast cancer and cervical cancer. 8 All three screening programmes were found to be associated with high levels of favourable health behaviours and beliefs. However, the methodological quality of most studies included in the review was weak. Baseline measurements were rarely taken, and studies often failed to include a control group. 8 It is therefore difficult to determine the impact of screening on health behaviour from this review.
The impact of screening on health behaviour must be assessed in proper randomized controlled trials (RCTs) in which health behaviour is compared between unscreened and screened individuals. The aim of this review was to summarize the evidence from such trials, investigating the effects of risk factor screening and early detection of disease screening on health behaviour.
Methods

Search strategy
This review included RCTs studying the effects of screening on health behaviour in a screened group and an unscreened group. Systematic searches of electronic databases were conducted, including National Library of Medicine (Medline;  1966 (CCTR) . No language restrictions were used. The reference sections of the obtained articles were also studied and requests for unpublished studies were circulated among colleagues. A methodological filter to identify RCTs was used. 12 Possibly eligible papers were downloaded into Reference Manager.
Inclusion criteria were: randomized study on screening in healthy adults (aged 18 and above), measurement of health behaviour. Health behaviour was defined as any data on smoking habits, diet, exercise, alcohol consumption or adherence to guidelines of healthy living.
Studies were not included when they investigated health intentions only, when they focused solely on improving the uptake of screening, or reattendance at screening when next invited, or when they investigated the effect on families (significant others) and social environment.
When RCTs were found compared screened and unscreened individuals on clinical variables but did not mention any health behaviour variables, the corresponding author was contacted and asked whether he and his colleagues had collected such data. If so, these unpublished data were also included in the review.
Study selection
One reviewer (M.D.) assessed the title and abstract of references identified by the search strategy. The full reports of all potentially eligible trial were then obtained for further assessment of eligibility by two authors (M.D. and F.V.). Any disagreements were resolved by discussion.
Data extraction
Data regarding inclusion criteria, study characteristics and results (study design, participants, interventions and outcomes) were extracted.
Data analysis
Due to the small number of included studies and marked heterogeneity in the type of screening, study population, length of follow-up and outcome assessment measures, we made no attempts at statistically pooling the data in a meta-analysis. Instead a qualitative synthesis of the results is presented. All dichotomous variables were analyzed, if possible, with Chi-square statistics to compare differences between the screened and unscreened groups. For all statistical tests P-values ,0.05 were considered to represent statistically significance.
Results
Retrieval of papers
In total 1953 manuscripts were retrieved, of which 621 were duplicates. The remaining 1332 manuscripts were assessed for eligibility by reading title and abstract. This resulted in 107 potentially eligible trials. Based on the complete manuscripts 100 of these studies could not be included. In total, seven trials 13 -19 met our inclusion criteria (see Fig. 1 ).
General characteristics of the studies Table 1 summarizes the characteristics of the seven included trials. Five studies dealt with risk factor screening, of which four dealt with cardiovascular disease, 16 -19 and one with genetic screening for aldehyde dehydrogenase 2, an enzyme that plays a role in the metabolism of acetoaldehyde; patients with low enzyme activity who are heavy drinkers have a markedly increased risk for developing oesophageal cancer.
14 Only two studies dealt with screening for early detection of disease; one concerned screening for hearing impairment 15 and one colorectal cancer screening. 13 Two studies were performed in the UK, 17, 18 two in Canada, 16, 19 one in Norway, 13 one in Denmark 15 and one in Japan.
14 Six studies included men and women and one study included men only. 14 The smallest study 14 invited 329 patients and the largest over 18 000. 18 In four studies patients from general practitioners 15,17 -19 were invited, in two studies participants were recruited in the working place, 14, 16 in one study 14 individuals were randomly drawn from the population registry. The follow-up length varied from 3 months 19 to 5 years. 15 Different forms of health behaviour were studied: smoking in three studies, 13, 17, 18 diet in three studies, 13, 16, 18 exercise in two studies, 13, 18 alcohol consumption in two studies, 14, 18 and adherence to given advice (testing for cholesterol and avoidance of noise) in two studies. 15, 19 Risk factor screening Two studies investigated the effects of screening for cardiovascular screening on smoking. 17, 18 Screened individuals in the British Family Heart Study 17 showed a significantly lower smoking prevalence than unscreened individuals (19 versus 23%, P , 0.001) after 1 year. No difference between screened and unscreened participants was found in the OXCHECK study. 18 The smoking prevalence after 3 years was 25% in the screened group compared with 26% in the unscreened group (P ¼ 0.44). 19 The effect on diet was measured in two studies. 16, 18 The OXCHECK group 18 studied the use of full cream milk and the use of butter or margarine. Both were significantly lower in the screened group (respectively 23% and 22%) after 3 years compared with the unscreened group (31 and 31%, respectively; P , 0.01). In the study of Strychar et al., 16 after 4 months no differences were detected in nutrient intake (e.g. total energy, % energy of (saturated) fat and dietary C: received a health questionnaire that determined whether they were at risk of coronary heart disease without identifying the risk factors as related to coronary heart disease (n ¼ 1603)
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Of those needing a cholesterol test:
I: 11%; C: 1.8% (had a test) (P , 0.0001).
OXCHECK-group 18 Changes in physical exercise after screening were investigated in one study. 18 The proportion of patients reporting vigorous exercise more than once a month was, after 3 years, significantly higher in the group screened for cardiovascular diseases (29%) than in unscreened individuals (22%) (P ¼ 0.01).
Two studies investigated the effect of screening on alcohol consumption. 14, 18 In the cardiovascular screening study, no significant difference between the screened and unscreened group was observed. 18 High alcohol use defined as 'reported weekly intake of .21 units for men and .14 for women' was 11% in the control group and 10.4% in the screened group (P ¼ 0.55). No difference in weekly alcohol intake (measured in grams) was observed between individuals screened for ALDH2 and individuals not screened. 14 At follow-up, alcohol intake in the screened group at low risk increased by 22 g (baseline: 269 g) and in the control group by 19 g (baseline: 288 g; P-value not calculable; study authors reported it not significant). High-risk individuals in the screened group decreased their intake by 21 g (baseline: 211 g) whereas the control group increased their intake by 34 g (baseline: 218 g). However, overall there was no significant difference in change between the screened and unscreened group (P-value not calculable; not significant according to the study authors).
The study of Hutchison et al. 19 investigated to what extent follow-up recommendations were followed. In this study the effect of screening for hypercholesterolemia by means of a risk appraisal questionnaire on meeting the criteria for cholesterol testing (Toronto working group's criteria 20 ) was investigated. Of those without pre-existing coronary heart disease who met the criteria for cholesterol testing, 45 of 421 subjects in the screened group (11%) versus 9 of 504 subjects in the unscreened group (1.8%) had a cholesterol test performed during the 3 months after the initial questionnaire posting (P , 0.0001). Of the patients without a history of coronary heart disease who did not meet the criteria for testing, 30 of 1128 subjects in the screened group (2.7%) and 18 of 1099 subjects in the unscreened group (1.6%) had a cholesterol test during the 3 month follow-up period (P ¼ 0.175).
Effects of early detection of disease screening
Only two studies dealt with screening for early detection of disease. 13, 15 The study of Larsen et al. 13 investigated the effects of screening for colorectal cancer on smoking, diet and exercise. The study of Karlsmose et al. 15 investigated the effects of screening for hearing loss on exposure to noise.
In the trial of colorectal cancer smoking, 13 and diet were measured on a scale from 1 (never) to 6. For smoking '6'indicated '.20 cigarettes per day' and for diet 'consumption .3 times per day'. Exercise was measured on a scale from 2 to 12.
Unscreened individuals showed a decline in smoking of 0.14 points (baseline score: 2.49) versus 0.11 in the screened group (baseline score: 2.56) (P ¼ 0.013; P-value from original article and derived from linear regression analyses).
Diet was measured with various variables: servings of fruit, berries and vegetables, consumption of boiled potatoes, poultry, meat, fatty fish and chocolate. The screened group lowered their consumption of fruit, berries and vegetables with 0.13 points (baseline score: 2.28), whereas the unscreened group increased their intake with 0.04 points (baseline score: 2.15; difference between screened and unscreened group: 0.17: P ¼ 0.001; derived from linear regression analyses). No difference in intake was detected between the screen negatives and the screen positives (P ¼ .346).
The improvement in the amount of exercise in the screened group was significantly lower (P , 0.001) than in the unscreened group (þ0.01 (baseline: 6.09) versus þ 0.21 (baseline: 5.89)).
The study of screening for hearing loss found that after screening 15 there was a significant change in exposure to leisure noise between screened and unscreened individuals (42 and 49%, respectively; P ¼ 0.045) after 5 years. However, no differences were detected for exposure to occupational noise (screened: 46%; unscreened: 50%: 95% CI of difference: 210.6 to 2.6) and to the use of hearing protection (screened: 42%; unscreened: 47%: 95% CI of difference: 24.0 to 14.7).
Summary of the results
In table 2 a summary of the results is shown. For all five health behaviour variables (smoking, diet, exercise, alcohol consumption and adherence) we list whether the outcome was better, equal or worse in the screened group compared with the unscreened group.
Discussion
The number of trials studying the effect of screening on health behaviour appears to be very limited. The trials on screening for risk factors provide indications to suggest a positive effect on health behaviour, while the number of trials on screening for early detection of disease was too small to allow for conclusions on effects on health behaviour.
The present review has several limitations. As in every systematic review we had to rely on published studies. When studies are not published it is extremely difficult to find them. It is known that studies with negative results are less likely to be published, 21 both due to researcher's reluctance to submit the manuscript or the journal's unwillingness to publish them. This publication bias may have resulted in an underestimation of the negative effects of screening on health behaviour.
The Mesh term 'Mass Screening' was used instead of the text word 'screening'. We decided to do so as 'screening' is a widely used term and we were only interested in large population-based screening programmes. This choice may have resulted in missing studies, which were not adequately provided with the appropriate Mesh term. For 1998 we checked in Medline whether using 'screening' as text word provided extra included trials compared with the Mesh term 'Mass Screening'. No additional trials were found.
The search strategy resulted in 1332 titles from which only seven studies could be included. Most studies were excluded because they were not set up as an RCT or the study did not report on health behaviour. The decision to include only RCTs may have led to the exclusion of a number of cohort studies. This is certainly the case for wellestablished screening programmes, such as cervical cancer screening or breast cancer screening, where it is considered unfeasible and unethical to randomize participants into a screening group and a non-screening group. Unfortunately, the number of screening trials that included health behaviour as an outcome measure appeared to be very limited. As health behaviour is not the primary outcome measure in most screening programmes, it is possible that health behaviour was studied but not reported in some trials. We contacted all eleven corresponding authors 22 -32 of reports on screening RCTs in which a screened group and an unscreened group had been compared. None of the eight responding authors reported to have collected these data.
The present review is the first to summarize all existing evidence on the relation between screening and health behaviour. The results of our review are of importance for public health. In an era where unhealthy behaviour accounts for a substantial part of the total burden of disease and the availability of screening programmes has continued to increase, the effect of screening on health behaviour is essential. Results of our review indicate that screening influences health behaviour in a positive direction for risk factor screening, while the number of trials on screening for early detection of disease was too small to allow for conclusions on effects on health behaviour.
In most risk factor screening programmes, especially screening for cardiovascular diseases, participants are recommended to make beneficial health behaviour changes. It is encouraging to see that in this review in three of four cardiovascular screening trials small improvements in health behaviour were observed. More information is necessary concerning the stability of these changes and the effects in groups difficult to reach (for instance migrants and subjects with a low socio-economic status). Participants in the OXCHECK study were on the average relatively healthy and from higher social class. 33 These participants may be more inclined and more able to change their health behaviour. This finding is consistent with other studies, which showed that attendance of a health check at the general practitioner 
þ, health behaviour better in screened compared to unscreened group; 2, health behaviour worse in screened compared to unscreened group; ¼, no difference in health behaviour between screened and unscreened group; *, worse health behaviour in screen negatives compared to screen positives.
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was lowest among those from the lower social class. 33 -35 This trend can also be observed in other preventive initiatives, as the uptake of cancer screening is lowest in those who are most socially deprived. 36 -39 The study on risk factor screening in which no improvement in health behaviour was observed was conducted in maintenance workers, i.e. a population with a low socio-economic status.
It is striking that in the extensive field of screening studies only seven RCT studies could be found on the relationship between screening and health behaviour. This paucity of included trials calls for including health behaviour effects in all future RCTs on the effectiveness of screening interventions. The indications that screening for early detection of diseases may have unintended negative side effects on health behaviour warrants further exploration. Beneficial effects of screening are often small and accrue over a long time. Therefore, any small harm in health behaviour change across a large number of people may outweigh the benefit gained by screening. Alternatively, small positive behaviour changes among screening participants may enhance the beneficial health effects of screening programmes. From our analysis, it seems that different types of screening (risk factor and early disease screening) may impact on individual's health behaviour patterns differently. More research to explicate this relationship is needed.
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